Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Dey, Pranay1,2 (AUTHOR), Joshi, Mansi1,2 (AUTHOR), Mujawar, Aaiyas1,2 (AUTHOR), Malhotra, Renu1 (AUTHOR), De, Abhijit1,2 (AUTHOR) ade@actrec.gov.in
Publikováno v:
Cellular Oncology (2211-3428). Oct2022, Vol. 45 Issue 5, p873-891. 19p.
Autor:
Li, Mingxue1 (AUTHOR), Wu, Canrong2 (AUTHOR), Yang, Yueying1 (AUTHOR), Zheng, Mengzhu2 (AUTHOR), Yu, Silin3 (AUTHOR), Wang, Jinhui3 (AUTHOR) tcm_syphu@163.com, Chen, Lixia1 (AUTHOR) syzyclx@163.com, Li, Hua1,2 (AUTHOR) li_hua@hust.edu.cn
Publikováno v:
Cellular Oncology (2211-3428). Jun2021, Vol. 44 Issue 3, p541-556. 16p.
Autor:
Ogrodzinski, Martin P.1,2 (AUTHOR), Teoh, Shao Thing1 (AUTHOR), Lunt, Sophia Y.1,3 (AUTHOR) sophia@msu.edu
Publikováno v:
Cellular Oncology (2211-3428). 2020, Vol. 43 Issue 6, p1117-1127. 11p.
Publikováno v:
Cellular Oncology (2211-3428). Feb2016, Vol. 39 Issue 1, p89-95. 7p.
Autor:
Rogers, T. L.1, Wind, N.1, Hughes, R.1, Nutter, F.1, Brown, H. K.1, Vasiliadou, I.1, Ottewell, P. D.1, Holen, I.1 I.Holen@Sheffield.ac.uk
Publikováno v:
Cellular Oncology (2211-3428). Dec2013, Vol. 36 Issue 6, p505-514. 10p.
siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells.
Autor:
Bagheri, Fatemeh1,2, Safarian, Shahrokh1 safarian@khayam.ut.ac.ir, Eslaminejad, Mohamadreza Baghaban2 eslami@royaninstitute.org, Sheibani, Nader3
Publikováno v:
Cellular Oncology (2211-3428). Dec2013, Vol. 36 Issue 6, p515-526. 12p.
Autor:
Zhan, Jun-Fang1, Wu, Liang-Ping2, Chen, Long-Hua3, Yuan, Ya-Wei3 jfzok@163.com, Xie, Guo-Zhu3, Sun, Ai-Min3, Liu, Ying3, Chen, Zhi-Xian3
Publikováno v:
Cellular Oncology (2211-3428). Oct2011, Vol. 34 Issue 5, p451-456. 6p.